Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 2 study of sunitinib in refractory thyroid cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 2 study of sunitinib in refractory thyroid cancer.
Phase 2 study of sunitinib in refractory thyroid cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):6025.
View in:
PubMed
authors with profiles
Ezra Cohen